These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10986192)

  • 1. Eye disorders: bacterial conjunctivitis.
    Chung CW; Cohen EJ
    West J Med; 2000 Sep; 173(3):202-5. PubMed ID: 10986192
    [No Abstract]   [Full Text] [Related]  

  • 2. Are topical antibiotics effective in treating bacterial conjunctivitis?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Sep; 50(9):801. PubMed ID: 11674916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of bacterial conjuntivitis with topical ciprofloxacin and norfloxacin: a comparative study].
    Chisari G; Sanfilippo M; Reibaldi M
    Infez Med; 2003 Mar; 11(1):25-30. PubMed ID: 12719667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection.
    Vyas U; Desai T; Shah C
    J Indian Med Assoc; 2002 Jun; 100(6):398-9. PubMed ID: 12416674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%.
    Tabbara KF; El-Sheikh HF; Islam SM; Hammouda E
    Eur J Ophthalmol; 1999; 9(4):269-75. PubMed ID: 10651190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial conjunctivitis in children: antibacterial treatment options in an era of increasing drug resistance.
    Pichichero ME
    Clin Pediatr (Phila); 2011 Jan; 50(1):7-13. PubMed ID: 20724317
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lomefloxacin in treatment of infectious eye diseases].
    Maĭchuk IuF; Vakhova ES; Kononenko LA
    Antibiot Khimioter; 1998; 43(10):32-5. PubMed ID: 9825108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of current antibiotics for the treatment of bacterial conjunctivitis.
    Karpecki P; Paterno MR; Comstock TL
    Optom Vis Sci; 2010 Nov; 87(11):908-19. PubMed ID: 20838353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute bacterial conjunctivitis].
    Høvding G
    Tidsskr Nor Laegeforen; 2004 Jun; 124(11):1518-20. PubMed ID: 15195156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
    Gallenga PE; Lobefalo L; Colangelo L; Della Loggia G; Orzalesi N; Velati P; Bujtar E; Ponte F; Damiani S; Bucci MG; Bonini S; Curatola MR; Palma LA; Bonomi L; Tomazzoli Gerosa L; Pagliarusco A; Milan E; Jauch A
    Ophthalmologica; 1999; 213(4):250-7. PubMed ID: 10420109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical fluoroquinolones for eye and ear.
    Morden NE; Berke EM
    Am Fam Physician; 2000 Oct; 62(8):1870-6. PubMed ID: 11057842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular applications of povidone-iodine.
    Isenberg SJ; Apt L; Campeas D
    Dermatology; 2002; 204 Suppl 1():92-5. PubMed ID: 12011529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
    Chang MH; Fung HB
    Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug information: Besivance.
    JAAPA; 2009 Oct; 22(10):12. PubMed ID: 19902825
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of chlamydial conjunctivitis.
    Nakagawa H
    Ophthalmologica; 1997; 211 Suppl 1():25-8. PubMed ID: 9065934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
    Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
    Comstock TL; Paterno MR; Usner DW; Pichichero ME
    Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin exhibits negligible serum concentrations after repeated conjunctival instillation in children.
    Drago F; La Manna C; Marino V; Marino A; Emmi I; Reibaldi A
    Br J Clin Pharmacol; 1998 Sep; 46(3):272-4. PubMed ID: 9764971
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of acute infective conjunctivitis.
    Drug and Therapeutics Bulletin
    Drug Ther Bull; 2011 Jul; 49(7):78-81. PubMed ID: 21733975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis].
    Zhang M; Hu Y; Chen F
    Yan Ke Xue Bao; 2000 Jun; 16(2):146-8. PubMed ID: 12579927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.